CG MedTech

056090 · KOSDAQ · ₩056090 · 시지메드텍

₩4,370▼ ₩75 (1.69%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y −10.45%
Market cap
₩90B
Enterprise value
₩98B
P/E
13.8×
P/B
0.9×
Dividend yield
0.0%
ROE
6.8%
Net margin
12.8%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−75.4% from the high

₩4,220Today: ₩4,325 – ₩4,510₩17,775

Returns

  • 1W−11.7%
  • 1M−26.6%
  • 3M+1.2%
  • 6M−55.8%
  • YTD−25.2%
  • 1Y−10.5%
Volume today
41,206
0.6× the 20-day average
Traded today
₩181M
Listed shares
20,651,807
EPS (12 months)
₩317
Earnings yield 7.3%
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.

Upcoming dates

Full calendar →

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

Signals

37Quiet
  • BuzzQuietBuzz 37 of 100 (50 is a normal day for this stock).
  • SentimentMixedNews: One neutral headline about a partnership, with no detail on its impact. Community: 0 bullish, 0 bearish posts this week.
  • MomentumWeak-26.6% over the last month; the price is below its 20-day average.
  • News impactLow3 news items and filings in two weeks; 0 rated high impact, 0 medium.

Signals describe activity, not recommendations. Not financial advice.

CG MedTech stock overview

CG MedTech (시지메드텍, KRX: 056090) is listed on KOSDAQ, in the Medical & precision devices sector. The company operates two business segments: medical devices and electrical energy. Its shares closed at ₩4,370 on Oct 28, 2026, down 1.69% on the day, giving it a market value of ₩90B.

Key facts

Market cap
₩90B
Sector
Medical & precision devices
Latest price change
−1.69%
As of
Oct 28, 2026
Main business
The company operates two business segments: medical devices and electrical energy.

Quick answers about CG MedTech

What does CG MedTech do?
The company operates two business segments: medical devices and electrical energy. Its medical device segment makes orthopedic products such as spinal fixation devices, fracture treatment devices, minimally invasive devices, bioabsorbable metal implants, dental implants and spinal bone graft materials. Its electrical energy segment supplies electricity meters, heat meters, electric vehicle chargers and testing equipment, and takes part in government-led smart metering and renewable energy projects.
What is the market cap of CG MedTech?
The market capitalisation of CG MedTech was ₩90B at the close on Oct 28, 2026.
Who are the largest shareholders of CG MedTech?
According to the latest official filings, the largest reported holders are Sijibio (42.41%, as of Oct 15, 2026).
When is the next earnings report from CG MedTech?
Korean companies rarely announce results dates in advance. Based on when CG MedTech filed the same report in past years, its next 3q results is expected around Nov 14, 2026.

Company profile

The company operates two business segments: medical devices and electrical energy. Its medical device segment makes orthopedic products such as spinal fixation devices, fracture treatment devices, minimally invasive devices, bioabsorbable metal implants, dental implants and spinal bone graft materials. Its electrical energy segment supplies electricity meters, heat meters, electric vehicle chargers and testing equipment, and takes part in government-led smart metering and renewable energy projects.

Written by AI from the company's latest annual report.

Korean name
시지메드텍
CEO
유현승
Founded
Aug 1997
Listed
Nov 2015
Listed shares
20,651,807
Fiscal year ends
Month 12
Website
cgmedt.com

Similar companies

Recent news

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: CG MedTech / 시지메드텍 / 056090 / KRX:056090

Source: KRX statistical information